Samnidhy | Company Analysis

Company Analysis of Sun Pharma

Company Analysis Tega

Sun Pharmaceutical Industries Ltd, the fourth largest specialty generic pharmaceutical company globally with revenues exceeding US$ 5.1 billion, operates a network of over 40 manufacturing facilities. This infrastructure enables them to provide high-quality, cost-effective medicines, positioning them as a trusted choice for healthcare professionals and patients in more than 100 countries. Founded in 1983 by Mr. Dilip Shanghvi with an initial investment of INR 10,000 (US$150), Sun Pharma initially served as a pharmaceutical wholesaler.

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

Company Analysis of ZF Commercial

Company Analysis Campus The company strategically shapes the future of commercial transportation...

Company Analysis of Wipro Limited.

Company Analysis Campus Founded in 1980 as a fledgling vegetable oil trader,...

Company Analysis of Hindustan Aeronautics Limited

Company Analysis Campus Hindustan Aeronautics Limited(HAL) was formed in 1964 following the...

Company Analysis of Gujarat Fluorochemicals

Company Analysis Campus Gujarat Fluorochemicals Limited (GFL) is an Indian company specializing...